HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 7,760.00
-90.00 (-1.15%)
Aug 24, 2026, 10:33 AM KST
HLB Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Cash & Equivalents | 4,507 | 7,609 | 10,492 | 2,744 | 3,030 | 5,350 |
Short-Term Investments | 14,677 | 14,528 | 11,500 | 1,310 | 235 | 525 |
Trading Asset Securities | - | - | - | 11,109 | 5,842 | 5,514 |
Cash & Short-Term Investments | 19,184 | 22,137 | 21,992 | 15,163 | 9,107 | 11,389 |
Cash Growth | -32.75% | 0.66% | 45.04% | 66.50% | -20.04% | - |
Accounts Receivable | 24,453 | 22,833 | 16,095 | 7,910 | 6,044 | 6,382 |
Other Receivables | 820.98 | 1,395 | 1,408 | 156.15 | 163.97 | 128.86 |
Receivables | 25,274 | 24,227 | 17,504 | 8,066 | 6,218 | 6,521 |
Inventory | 30,947 | 29,526 | 22,861 | 5,648 | 5,382 | 4,884 |
Prepaid Expenses | 516.64 | 151.11 | 178.25 | 47.26 | 428.26 | 242.13 |
Other Current Assets | 2,051 | 660.69 | 845.65 | 93.85 | 140.41 | 230.82 |
Total Current Assets | 77,973 | 76,702 | 63,381 | 29,018 | 21,275 | 23,267 |
Property, Plant & Equipment | 44,384 | 44,388 | 34,020 | 15,315 | 13,304 | 13,323 |
Long-Term Investments | 50,148 | 45,204 | 55,078 | 146.5 | 1,265 | 1,789 |
Goodwill | 105.07 | 105.07 | - | - | - | - |
Other Intangible Assets | 4,924 | 3,670 | 4,448 | 446.2 | 282.13 | 188.45 |
Long-Term Deferred Tax Assets | - | - | - | 208.27 | 6.99 | 1,002 |
Long-Term Deferred Charges | 84.4 | 185.53 | 387.79 | 629.76 | 129.67 | - |
Other Long-Term Assets | 410.67 | 428.28 | 620.27 | 82.12 | 160.27 | 277.32 |
Total Assets | 178,029 | 170,682 | 157,933 | 45,846 | 36,423 | 39,846 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Accounts Payable | 12,217 | 10,257 | 8,718 | 2,404 | 4,856 | 2,261 |
Accrued Expenses | 7,430 | 6,619 | 8,133 | 4,593 | 2,092 | 2,241 |
Short-Term Debt | 15,000 | 15,000 | 15,000 | 8,458 | 4,854 | 1,725 |
Current Portion of Long-Term Debt | - | - | - | 780 | 1,580 | 10,388 |
Current Portion of Leases | 1,470 | 1,540 | 763.8 | 426.67 | - | - |
Current Income Taxes Payable | - | - | - | - | 105.9 | - |
Other Current Liabilities | 5,264 | 6,212 | 6,017 | 6,429 | 2,736 | 1,126 |
Total Current Liabilities | 41,381 | 39,628 | 38,632 | 23,092 | 16,224 | 17,741 |
Long-Term Debt | - | - | - | 1,580 | 1,260 | 2,840 |
Long-Term Leases | 3,520 | 4,144 | 290.77 | 1,954 | - | - |
Pension & Post-Retirement Benefits | 1,980 | 1,436 | 937.15 | 1,166 | 1,521 | 2,375 |
Long-Term Deferred Tax Liabilities | 390 | 325.35 | 1,672 | - | 314.93 | - |
Other Long-Term Liabilities | -0 | 0 | 0 | 151.41 | 105.72 | 88.99 |
Total Liabilities | 47,272 | 45,534 | 41,532 | 27,943 | 19,425 | 23,045 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Common Stock | 16,400 | 16,400 | 15,907 | 6,924 | 6,924 | 6,247 |
Additional Paid-In Capital | 61,981 | 61,981 | 93,433 | 8,435 | 17,304 | 15,263 |
Retained Earnings | 56,999 | 56,368 | 1,971 | 1,215 | -8,453 | -5,410 |
Treasury Stock | -5.6 | -5.6 | -5.6 | -5.6 | -5.6 | -5.6 |
Comprehensive Income & Other | -4,616 | -9,594 | 5,096 | 1,334 | 1,229 | 707.13 |
Shareholders' Equity | 130,758 | 125,149 | 116,402 | 17,903 | 16,998 | 16,802 |
Total Liabilities & Equity | 178,029 | 170,682 | 157,933 | 45,846 | 36,423 | 39,846 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Total Debt | 19,990 | 20,684 | 16,055 | 13,198 | 7,694 | 14,953 |
Net Cash (Debt) | -806.13 | 1,453 | 5,938 | 1,965 | 1,413 | -3,564 |
Net Cash Growth | - | -75.53% | 202.18% | 39.05% | - | - |
Net Cash Per Share | -24.29 | 44.45 | 185.20 | 141.88 | 104.39 | -297.72 |
Filing Date Shares Outstanding | 28.33 | 32.8 | 31.81 | 13.85 | 13.85 | 12.49 |
Total Common Shares Outstanding | 28.33 | 32.8 | 31.81 | 13.85 | 13.85 | 12.49 |
Working Capital | 36,591 | 37,073 | 24,749 | 5,927 | 5,052 | 5,526 |
Book Value Per Share | 4615.19 | 3815.65 | 3658.77 | 1292.83 | 1227.52 | 1344.92 |
Tangible Book Value | 125,728 | 121,374 | 111,954 | 17,457 | 16,716 | 16,613 |
Tangible Book Value Per Share | 4437.67 | 3700.57 | 3518.98 | 1260.61 | 1207.15 | 1329.84 |
Land | 26,792 | 26,792 | 26,792 | 1,239 | 1,239 | 1,239 |
Buildings | 2,172 | 3,697 | 3,697 | 8,520 | 8,472 | 8,581 |
Machinery | 15,927 | 15,616 | 15,770 | 9,673 | 8,772 | 9,892 |
Construction In Progress | 6,375 | 6,523 | 1,658 | 382.9 | 183.6 | 136.94 |